|
PDUFA V Appears to Authorize FDA to Require Supplier Quality Deals: Expert
BALTIMORE — Proposed language redefining cGMPs included in both versions of omnibus FDA user fee legislation appears to give the agency new authority to require drugmakers to make supplier quality agreements, a compliance expert says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives